Biotech news
Biotech
Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement. 20 October 2020
Pharma
The English High Court has concluded that Merck Sharp Dohme is not infringing a patent owned by Pfizer through the sale of its pneumococcal conjugate vaccine. 20 October 2020
Americas
Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper. 19 October 2020
Biotech
A unit belonging to German company Braun has allegedly infringed five patents relating to artificial joints for knee and hip replacements, according to a complaint filed by the Orthopaedic Institute for Children. 13 October 2020
Pharma
Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over. 12 October 2020
Pharma
South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries. 8 October 2020
Biotech
Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein. 6 October 2020
Americas
Bristol Myers Squibb has announced it will acquire biotech firm MyoKardia for $13.1 billion, strengthening its portfolio of heart disease treatments. 6 October 2020
Americas
Antimicrobial company PureShield has accused its competitor Allied BioScience of infringing ten patents through the sale of a surface disinfectant, which claims protection against COVID-19 for up to seven days. 30 September 2020
Biotech
The Federal Court of Australia has rejected Boehringer Ingelheim’s animal health unit's attempt to stop the registration of a patent owned by Intervet International on various grounds. 21 September 2020